Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Pierre Fabre investigates ACAT inhibitors

Sep. 20, 1996

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

Pfizer describes anticancer application for known antidepressant

Sep. 20, 1996

Novel anticancer tyrosine kinase inhibitors from Pharmacia & Upjohn

Sep. 20, 1996

HEK4-binding protein from Amgen

Sep. 20, 1996

RPR reports novel protein farnesyltransferase inhibitors

Sep. 20, 1996

CI-958 for treatment of prostate cancer

Sep. 20, 1996

SAMDC inhibitors from Ciba-Geigy

Sep. 20, 1996

Nitrogen mustard prodrugs from CRC Technology

Sep. 20, 1996

New formulation of ciclosporin

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld Science
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...